Sirion Therapeutics is Ready to Develop New Treatment for Viral and Superficial Eye Infection sirion療法已準備制定新的治療病毒性心肌炎及淺表眼部感染
Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceuticals company, announced today that it has reached an exclusive licensing agreement with Laboratoires Thea of France for the US rights to develop and market a topical ophthalmic gel containing ganciclovir for the treatment of certain viral and superficial eye infections. sirion Therapeutics公司，眼科為重點的生物製藥公司，今天宣布它已經達成了一項獨家授權協議與laboratoires茶的法國為美國發展權，並為市場提供了局部眼用凝膠含有更昔洛韋用於治療某些病毒性疾病和膚淺眼感染。 The product is currently marketed by Thea in Europe under the brand name of Virgan(R).該產品目前銷售的茶在歐洲下的品牌名稱virgan （ R組） 。
According to Dr. C. Stephen Foster, Founder and President of Massachusetts Eye Research and Surgery Institute (MERSI), Clinical Professor of Ophthalmology, Harvard Medical School, upon regulatory approval, ganciclovir gel would become the first topical ophthalmic anti-viral treatment launched in the US in over two decades.據葉文長史蒂芬福斯特，創始人和主席的馬薩諸塞州眼科研究和外科學會（梅爾西） ，臨床教授，眼科，哈佛醫學院的，一經監管機構的批准，更昔洛韋凝膠將成為第一個專題眼科抗病毒治療啟動美國在超過20年。 This product has the potential to advance the medical treatment of herpes simplex keratitis.這個產品有潛力，推進醫療治療單純皰疹病毒性角膜炎。 Herpes simplex keratitis remains the leading cause of corneal blindness in the United States.單純皰疹病毒性角膜炎仍然是導致角膜盲症在美國。
According to data published in the journal Archives of Ophthalmology, herpes simplex keratitis affects up to 500,000 people in the United States.據公佈的數據顯示，在該雜誌的檔案眼科，單純皰疹性角膜炎的影響多達50萬人在美國。
Each year, ocular herpes simplex virus is estimated to affect approximately 50,000 people in the United States, arising as acute primary disease in 20,000 people and as recurrent disease in an additional 28,000.每年，眼部單純皰疹病毒，估計影響到大約50000人，在美國，因急性原發性疾病20000人，並作為經常性的疾病，是增加28000人。
You may also like to read您可能還喜歡讀
- Highly Infectious Viral Conjunctivitis Affecting All Age Groups傳染性很強的病毒性結膜炎的影響所有年齡組
- Contagious Eye Infection Going Around Bostonia Community傳染性眼睛感染四出奔走bostonia社區
- Bayer and Regenron Agreed to Jointly Develop Treatment for Eye Disease拜耳和regenron同意共同開發治療眼科疾病
- Outbreak of Conjunctivitis (Eye Infection) in the Rhondda Fach Valley爆發性結膜炎（眼部感染） ，在信息Rhondda fach谷
- Before Laser Eye Surgery: Some Important Tips前激光眼科手術：一些重要的秘訣
- Rift Valley Fever Can Cause Serious Eye Infection and Can Also Claim Human Lives裂谷熱，可引起嚴重的眼部感染，還可以索賠人命
- Bausch & Lomb Facings Class Action Lawsuit for Fusarium Kerititus - Renu Link博士倫面向集體訴訟，為鐮刀菌kerititus -連接的R enu
- Virtual Eye Surgery Make a Big Difference in the Operating Room虛擬眼科手術，使一個大的差異，在手術室
- Pfizer Antibiotic Zithromax for Eye Infection May Bring Re-Infections輝瑞抗生素希舒美眼科感染可能帶來重新感染
- Early Detection And Treatment Of Eye Is Essential For Children及早發現和治療眼睛是必不可少的孩子
